Genome-resolved multi-omics characterizes bacterial, viral, and metabolic components associated with Parkinson’s disease gut ecosystem variation

Parkinson’s disease (PD) is increasingly recognized as a disorder involving the gut-brain axis, yet genome-resolved characterization of bacterial and viral communities with metabolic context remains limited. Here, we performed deep shotgun metagenomic sequencing and fecal metabolomic profiling in a high-altitude cohort comprising patients with PD and environmentally matched spouse controls (living at approximately 1,900 m altitude). We reconstructed 455 species-level genome bins (SGBs) and 2,957 non-redundant viral operational taxonomic units (vOTUs), enabling high-resolution profiling of bacterial and viral community composition. Rather than a uniform shift of the entire microbial community, PD-associated variation involved specific bacterial, viral, and metabolic components. Indicator analysis identified 23 bacterial and 86 viral candidate indicators associated with PD or control status, with predicted temperate phages representing the predominant lifestyle category among indicator vOTUs. Several PD-associated bacterial indicators included taxa previously linked to anaerobic fermentation and short-chain fatty acid (SCFA)-associated metabolism, accompanied by increased fecal valerate. Abundance correlation analysis identified covariation patterns between bacterial and viral indicators, including associations between controls (CK)-associated Agathobacter faecis and Lachnospiraceae-linked vOTUs. Integrating microbial abundance profiles and metabolomic measurements revealed exploratory associations among microbial indicators and metabolic alterations associated with PD. Cross-layer analyses further showed reduced dispersion of microbial-metabolomic alignment patterns in PD samples, suggesting a more constrained ecological state. Together, these findings provide a genome-resolved view of bacterial, viral, and metabolic variation in the PD gut ecosystem, extending characterization of PD-associated dysbiosis beyond bacterial taxonomy and identifying candidate microbial indicators and metabolic alterations for further investigation. IMPORTANCE Parkinson’s disease (PD) is a complex neurological disorder in which interactions between the host and the gut ecosystem are increasingly recognized as relevant to disease-associated biological processes. Previous microbiome studies of Parkinson’s disease have largely focused on bacterial taxonomic changes, while gut viral communities and their relationships with microbial metabolism remain less characterized. In this study, we used genome-resolved metagenomics and metabolomics to characterize bacterial, viral, and metabolic components associated with PD in individuals with Parkinson’s disease and environmentally matched controls. Our findings provide a broader view of Parkinson’s disease-associated gut ecosystem alterations beyond bacterial composition alone, highlighting bacteriophages as an underexplored ecological component and identifying microbial indicators and metabolic alterations for future investigation.

Authors

Institutions

Publication Details

Journal
Microbiology Spectrum
Published
2026-11-18
DOI
https://doi.org/10.1128/spectrum.02337-26
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Genome-resolved multi-omics characterizes bacterial, viral, and metabolic components associated with Parkinson’s disease gut ecosystem variation

Ninghui Zhao, Zhigang Zhang, Jinyuan Yan, Debin Zhao et al.
1 links
Microbiology Spectrum
Gut microbiota and health
article

Genome-resolved multi-omics characterizes bacterial, viral, and metabolic components associated with Parkinson’s disease gut ecosystem variation

Ninghui Zhao, Zhigang Zhang, Jinyuan Yan, Debin Zhao, Wenhu Li, Yutao Fu, Wenwen Liu, Guoyong Shi, Ying wang, Minhao Huang, Yan Li, Tingting Wu, Daohua Zhuang, Guolin Shi
article en

Abstract

Parkinson’s disease (PD) is increasingly recognized as a disorder involving the gut-brain axis, yet genome-resolved characterization of bacterial and viral communities with metabolic context remains limited. Here, we performed deep shotgun metagenomic sequencing and fecal metabolomic profiling in a high-altitude cohort comprising patients with PD and environmentally matched spouse controls (living at approximately 1,900 m altitude). We reconstructed 455 species-level genome bins (SGBs) and 2,957 non-redundant viral operational taxonomic units (vOTUs), enabling high-resolution profiling of bacterial and viral community composition. Rather than a uniform shift of the entire microbial community, PD-associated variation involved specific bacterial, viral, and metabolic components. Indicator analysis identified 23 bacterial and 86 viral candidate indicators associated with PD or control status, with predicted temperate phages representing the predominant lifestyle category among indicator vOTUs. Several PD-associated bacterial indicators included taxa previously linked to anaerobic fermentation and short-chain fatty acid (SCFA)-associated metabolism, accompanied by increased fecal valerate. Abundance correlation analysis identified covariation patterns between bacterial and viral indicators, including associations between controls (CK)-associated Agathobacter faecis and Lachnospiraceae-linked vOTUs. Integrating microbial abundance profiles and metabolomic measurements revealed exploratory associations among microbial indicators and metabolic alterations associated with PD. Cross-layer analyses further showed reduced dispersion of microbial-metabolomic alignment patterns in PD samples, suggesting a more constrained ecological state. Together, these findings provide a genome-resolved view of bacterial, viral, and metabolic variation in the PD gut ecosystem, extending characterization of PD-associated dysbiosis beyond bacterial taxonomy and identifying candidate microbial indicators and metabolic alterations for further investigation. IMPORTANCE Parkinson’s disease (PD) is a complex neurological disorder in which interactions between the host and the gut ecosystem are increasingly recognized as relevant to disease-associated biological processes. Previous microbiome studies of Parkinson’s disease have largely focused on bacterial taxonomic changes, while gut viral communities and their relationships with microbial metabolism remain less characterized. In this study, we used genome-resolved metagenomics and metabolomics to characterize bacterial, viral, and metabolic components associated with PD in individuals with Parkinson’s disease and environmentally matched controls. Our findings provide a broader view of Parkinson’s disease-associated gut ecosystem alterations beyond bacterial composition alone, highlighting bacteriophages as an underexplored ecological component and identifying microbial indicators and metabolic alterations for future investigation.

Microbiology Spectrum
Kunming Institute of Zoology (CN), Yunnan University (CN), Chinese Academy of Sciences (CN), Kunming Medical University (CN), Second Affiliated Hospital of Kunming Medical College (CN), Chuxiong Normal University (CN), University of Hong Kong (HK)
Yunnan University
Good health and well-being
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon